Christopher O. is a Principal Scientist at Capsida Biotherapeutics specializing in AAV-based gene therapy for CNS and cardiac indications. With a Ph. D. from the University of Rhode Island, he leads discovery and IND-enabling programs by integrating in vivo pharmacology, disease modeling, and next-generation viral vectors.
He was a featured speaker at the 5th Annual CNS Drug Delivery Summit, presenting new preclinical data on CNS-targeted capsids.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.